The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation

Annals of Surgery

Volumn 247, Issue 6, 2008, Pages 1049-1057

  Man, Kwan ^a,c   Lo, Chung Mau ^a   Xiao, Jiang Wei ^a,b   Ng, Kevin T ^a   Sun, Bai Shun ^a   Ng, Irene O ^a   Cheng, Qiao ^a   Sun, Chris K ^a   Fan, Sheung Tat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; FOCAL ADHESION KINASE 2; RAC PROTEIN; RHO KINASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HEPATOMA CELL; INCIDENCE; LIVER TRANSPLANTATION; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; STELLATE CELL; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME; UPREGULATION; VEIN;

ACUTE-PHASE REACTION; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT SURVIVAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; ORGAN SIZE; RATS; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 44449132236     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31816ffab6XXX     Document Type: Article

References (29)

1. Cheng SJ, Pratt DS, Freeman RB, et al. Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysis. Transplantation. 2001;72:861-868.
2. Sarasin FP, Majno PE, Llovet JM, et al. Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and cost-effectiveness perspective. Hepatology. 2001;33:1073-1079.
3. Lo CM, Fan ST, Liu CL, et al. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl. 2004;10:440-447.
4. Gondolesi G, Munoz L, Matsumoto C, et al. Hepatocellular carcinoma: a prime indication for living donor liver transplantation. J Gastrointest Surg. 2002;6:102-107.
5. Kaihara S, Kiuchi T, Ueda M, et al. Living-donor liver transplantation for hepatocellular carcinoma. Transplantation. 2003;75:S37-S40.
6. Gondolesi GE, Roayaie S, Munoz L, et al. Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg. 2004;239:142-149.
7. Kulik L, Abecassis M. Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology. 2004;127:S277-S282.
8. Lo CM, Fan ST, Liu CL, et al. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg. 2007;94:78-86.
9. Man K, Fan ST, Lo CM, et al. Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg. 2003;237:256-264.
10. Yang ZF, Poon RT, Luo Y, et al. Up-regulation of vascular endothelial growth factor (VEGF) in small-for-size liver grafts enhances macrophage activities through VEGF receptor 2-dependent pathway. J Immunol. 2004;173:2507-2515.
11. Man K, Lo CM, Ng IO, et al. Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg. 2001;136:280-285.
12. Lee TK, Man K, Ho JW, et al. FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma. Clin Cancer Res. 2005;11:8458-8466.
13. Ho JW, Man K, Sun CK, et al. Effects of a novel immunomodulating agent, FTY720, on tumor growth and angiogenesis in hepatocellular carcinoma. Mol Cancer Ther. 2005;4:1430-1438.
14. Man K, Su M, Ng KT, et al. Rapamycin attenuates liver graft injury in cirrhotic recipient - the significance of down-regulation of Rho-ROCK-VEGF pathway. Am J Transplant. 2006;6:697-704.
15. Man K, Lo CM, Lee TK, et al. Intragraft gene expression profiles by cDNA microarray in small-for-size liver grafts. Liver Transpl. 2003;9:425-432.
16. van der Bilt JD, Kranenburg O, Nijkamp MW, et al. Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology. 2005;42:165-175.
17. Man K, Ng KTP, Lo CM, et al. Ischemia-reperfusion injury of small liver remnant promotes liver tumor metastasis - activation of cell invasion pathways. Liver Transplantation. 2007;13:1669-1677.
18. Wojciak-Stothard B, Ridley AJ. Shear stress-induced endothelial cell polarization is mediated by Rho and Rac but not Cdc42 or PI 3-kinases. J Cell Biol. 2003;161:429-439.
19. Tzima E, Del Pozo MA, Kiosses WB, et al. Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression. EMBO J. 2002;21:6791-6800.
20. Sahai E, Olson MF, Marshall CJ. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J. 2001;20:755-766.
21. Clark EA, Golub TR, Lander ES, et al. Genomic analysis of metastasis reveals an essential role for RhoC. Nature. 2000;406:532-535.
22. Itoh K, Yoshioka K, Akedo H, et al. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med. 1999;5:221-225.
23. Lipinski CA, Tran NL, Menashi E, et al. The tyrosine kinase pyk2 promotes migration and invasion of glioma cells. Neoplasia. 2005;7:435-445.
24. Olaso E, Salado C, Egilegor E, et al. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology. 2003;37:674-685.
25. Gao W, Washington MK, Bentley RC, et al. Antiangiogenic agents protect liver sinusoidal lining cells from cold preservation injury in rat liver transplantation. Gastroenterology. 1997;113:1692-1700.
26. Chao Y, Li CP, Chau GY, et al. Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery. Ann Surg Oncol. 2003;10:355-362.
27. Drixler TA, Vogten MJ, Ritchie ED, et al. Liver regeneration is an angiogenesis-associated phenomenon. Ann Surg. 2002;236:703-711.
28. Paku S, Kopper L, Nagy P. Development of the vasculature in "pushingtype" liver metastases of an experimental colorectal cancer. Int J Cancer 2005;115:893-902.
29. Nagy JA, Brown LF, Senger DR, et al. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta. 1989;948:305-326.